Article

1 Iconography
3 @@#116640@@
Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text
Advertising


Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates



Journal of the American Academy of Dermatology
Volume 50, n° 4
pages 635-639 (avril 2004)
Doi : 10.1016/S0190-9622(03)00883-1
What is the point of databases of reviews for dermatology if all they compile is “insufficient evidence”?
 

Eva R. Parker, MD b, Lisa M. Schilling, MD c, Victoria Diba, MRCP e, Hywel C. Williams, FRCP, PhD e, Robert P. Dellavalle, MD, PhD a, b, d,
a Veterans Affairs Medical Center, Denver, Colorado, USA 
b Department of Dermatology, University of Colorado School of Medicine, Denver, Colorado, USA 
c Department of Medicine, University of Colorado School of Medicine, Denver, Colorado, USA 
d Department of Preventive Medicine and Biometrics, University of Colorado School of Medicine, Denver, Colorado, USA 
e the Centre for Evidence-Based Dermatology, Queen's Medical Centre, Nottingham, United Kingdom 

*Reprint requests: Robert P. Dellavalle, MD, PhD, University of Colorado Health Sciences Center, 4200 E Ninth Ave, Box B-153, Denver, CO 80262, USA.
Abstract
Background

The use of review databases for dermatology has been questioned because of the impression that these reviews frequently report finding insufficient evidence to guide therapeutic recommendations.

Objective

We sought to determine the number of review database entries most relevant to dermatology (addressing diseases with skin manifestations whereby a dermatologist may be the primary caregiver) and the percentage of these entries that report sufficient evidence to guide clinical decision making.

Methods

We conducted computerized searches and analysis of reviews in the Cochrane Database of Systematic Reviews and the Database of Abstracts of Reviews of Effectiveness. Database entries were categorized using the face value reports of the original reviewers as: (1) finding sufficient evidence to inform clinical decisions; (2) finding insufficient evidence; or (3) unable to classify with regard to degree of evidence found.

Results

Of all review database entries, 3% (54/1235 in Cochrane Database of Systematic Reviews and 65/2208 in the Database of Abstracts of Reviews of Effectiveness) were deemed relevant to dermatology. In all, 14 entries from the Database of Abstracts of Reviews of Effectiveness were in the process of being written and not available for further evaluation. Of the remaining entries, 40% (42/105) reported finding sufficient evidence. Of the 10 most common dermatologic diagnoses, 8 were addressed in 30% (31/105) of these reviews. Of entries addressing common dermatologic diagnoses, 32% (10/31) reported finding sufficient evidence.

Conclusions

Although few (3%) entries in review databases currently address dermatology topics, entries address many (8/10) of the top 10 dermatology diagnoses. Contrary to popular belief, a substantial number (40%) of such reviews report sufficient evidence to inform clinical decisions making.

The full text of this article is available in PDF format.

 Supported by the National Cancer Institute Grant K-07 CA92550-01A1 (Dr Dellavalle).
Disclosure: Dr Williams is coordinating editor of the Cochrane Skin Group.



© 2004  American Academy of Dermatology, Inc.@@#104156@@
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Close
Article Outline
You can move this window by clicking on the headline